by Jasmine Batchelor
August 29, 2019
Director, Center for Health Policy and Outcomes,
Memorial Sloan-Kettering Cancer Center
Dr. Bach is a physician, epidemiologist, researcher, and healthcare policy expert who studies US pharmaceutical pricing and reimbursement policy. His work includes developing models for indication specific pricing, point of sale rebates, and subscription-based payment for drugs. In 2012, he and other Sloan Kettering physicians drew attention to the high price of the drug Zaltrap, leading the company to halve the drug’s price. He graduated from Harvard College, the University of Minnesota Medical School, and the Harris School for Public Policy at the University of Chicago. He has published more than 100 peer-reviewed articles and editorials in scientific journals such as the New England Journal of Medicine and the Journal of the American Medical Association and has been inducted into the National Academy of Medicine, the American Society for Clinical Investigation, and the Johns Hopkins Society of Scholars.